From The New Indian Express
Center Owned by Express Publications (Madurai) Ltd.Centre proposes immediate suspension of licences to manufacture drugs found 'Not of Standard Quality'
What's behind this
The government has put forward a proposal to immediately suspend the manufacturing licences of drugs that are deemed not of standard quality on certain critical quality parameters. Under the proposed amendment, a suspension would remain in effect until the manufacturer implements mandatory corrective measures, after which the licence could be revoked. The move is described as a major step to strengthen the regulatory framework and ensure the quality and safety of medicines in the country.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
left · 1 outlet
Proposed amendment provides for mandatory corrective measures before revocation of the suspension; suspension shall continue until the manufacturer undertakes corrective action
-
center · 3 outlets
New Delhi: The Union health ministry Wednesday said it has proposed immediate suspension of manufacturing licences for drugs found not of standard quality (NSQ) on critical parameters such as assay, dissolution and sterility, to ensure faster regulatory action against substandard medicines. The…
-
right · 1 outlet
The proposed changes seek to prevent substandard medicines from remaining in circulation while manufacturers address quality failures and regulatory concerns
RSS excerpt
NEW DELHI: In a major step towards strengthening the regulatory framework for ensuring the quality and safety of medicines in the country, the centre has proposed immediate suspension of manufacturing licences for drugs Not of Standard Quality (NSQ) on specified critical quality parameters. The…
